Table 1 Baseline characteristics.
From: Relative platelet reductions provide better pathophysiologic signatures of coagulopathies in sepsis
Total | 26,176 |
|---|---|
Male sex, n (%) | 13 514 (51.6) |
Age, years, mean (SD) | 66.16 (15.4) |
Admission weight, kg, mean (SD) | 84.07 (29.5) |
Ethnicity, n (%) | |
Caucasian | 20 370 (77.8) |
African American | 2752 (10.5) |
Asian | 418 (1.6) |
Hispanic | 1057 (4.1) |
Native American | 216 (0.8) |
Other/unknown | 1363 (5.2) |
Focus of infection, n (%) | |
Abdominal | 3596 (13.7) |
Pulmonary | 13,611 (50.9) |
Soft tissue | 1751 (6.6) |
Urinary tract | 3907 (14.6) |
Others/unknown | 3291 (12.3) |
Charlson comorbidity index, median (IQR) | 4 (2–6) |
SOFA score on admission, median (IQR) | 7 (5–10) |
APACHE IV score, median (IQR) | 65 (15–82) |
Platelet count (day 1), × 103/μL, median (IQR) | 181 (125–251) |
Platelet count (day 2), × 103/μL, median (IQR) | 174 (117–242) |
Treatment on day 1, n (%) | |
Mechanical ventilation | 1925 (7.3) |
Renal replacement therapy | 1108 (4.2) |
New coagulopathy-related complications after day 2 of ICU admission, n (%) | |
Hemorrhage | 145 (0.6) |
Thrombosis | 139 (0.5) |
In-hospital death, n (%) | 3208 (12.3) |
Length of hospital stay, days, median (IQR) | 7.4 (4.7–12.1) |
